Vimarsana
Biggest News Aggregation in the World

Background Therapy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Background Therapy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Background Therapy Today - Breaking & Trending Today

BBCNEWS Breakfast July 3, 2024 - Vimarsana News

BBCNEWS Breakfast July 3, 2024

A hollywood ending, watched by their hollywood fan. The twin who saved her sister from a crocodile is recognised by the king for her bravery. Good morning. A band of rain is slowly moving northward and eastward today. North east of Scotland Driest and warmest. The south west, sunny spells with scattered showers. I will have all the details later in the programme. Its tuesday 14th may. Our main story. A new study has found that anti obesity injections could reduce the risk of Heart Attacks and stroke, regardless of how much weight people lose. Researchers from University College london have des...

Findings from STELLAR Phase III Trial Presented at ACC23 Report Novel First-in-class Medication Shows Promise in Treating Rare Heart Lung Condition - Vimarsana News

Findings from STELLAR Phase III Trial Presented at ACC23 Report Novel First-in-class Medication Shows Promise in Treating Rare Heart Lung Condition

Significant improvements in six-minute walking distance were reported in the STELLAR Phase III Trial whose findings were unveiled during a Featured Clinical Research session on the final day of the March 4-6 American College of Cardiology Scientific Session, ACC23 Together with WCC. Researchers added a novel first-in-class medication in combination with background therapy in patients with pulmonary arterial hypertension (PAH), a severe, progressive condition that affects the heart and lungs.

89bio Presents New Analysis of Data from Phase 2 ENTRIGUE - Vimarsana News

89bio Presents New Analysis of Data from Phase 2 ENTRIGUE

– Post hoc analysis data demonstrated pegozafermin treatment significantly reduced triglycerides and other atherogenic lipids in patients with SHTG...